Central Sleep Apnea at High Altitude: From Pathophysiology to Treatment.

Authors

Elisa Perger, Sébastien Baillieul

Published in

Sleep medicine clinics. Volume 21. Issue 3. Pages 343-352. Epub Jul 06, 2026.

Abstract

At elevations above roughly 2500 m, susceptible individuals manifest central sleep apnea due to high-altitude periodic breathing (high-altitude central sleep apnea [HA-CSA]) characterized by a typical periodic breathing pattern. Mechanistically, HA-CSA develops when sleep-related decreases in respiratory drive, triggered by hypocapnia, resulting from hypoxia-induced hyperventilation, interact with increased loop gain during non-rapid eye movement sleep. Clinically, severity is mitigated by descent or supplemental oxygen. Pharmacologic strategies such as acetazolamide are effective, and sleep quality may improve with judicious hypnotic use independent of CSA severity. This article integrates the description of HA-CSA mechanisms, clinical expression, ethnic and chronic-exposure perspectives, and management strategies.

PMID:
42567625
Bibliographic data and abstract were imported from PubMed on 08 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.